Volume 87, Issue 1 pp. 13-18
Research Article

Clinical relevance of parasternal uptake in sentinel node procedure for breast cancer

Hans F.J. Fabry MD

Hans F.J. Fabry MD

Department of Surgical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Search for more papers by this author
Pim G.N.J. Mutsaers

Pim G.N.J. Mutsaers

Department of Surgical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Search for more papers by this author
Sybren Meijer MD, PhD

Sybren Meijer MD, PhD

Department of Surgical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Search for more papers by this author
Hans Torrenga

Hans Torrenga

Department of Surgical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Search for more papers by this author
Rik Pijpers MD, PhD

Rik Pijpers MD, PhD

Department of Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands

Search for more papers by this author
Paul A.M. Van Leeuwen MD, PhD

Paul A.M. Van Leeuwen MD, PhD

Department of Surgical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Search for more papers by this author
Joost R.M. van der Sijp MD, PhD

Corresponding Author

Joost R.M. van der Sijp MD, PhD

Department of Surgical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Department of Surgical Oncology, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam. Fax: +31/20/4444512Search for more papers by this author
First published: 21 June 2004
Citations: 9

Abstract

Background and Objectives

Preoperative lymphoscintigraphy contributes highly to the accuracy of the sentinel node procedure. Besides routing towards the axilla, in a number of patients additional parasternal focal accumulation may be observed. So far the clinical consequences of this parasternal uptake remains unclarified, i.e., whether any internal mammary lymph node uptake should be surgically biopsied. An analysis of all sentinel node procedures with parasternal uptake was performed.

Methods

Sixty-nine patients with scintigraphic parasternal uptake and with a minimal follow-up of 24 months, were selected from a prospective database. Tumor characteristics, treatment strategies, and recurrences of these patients were analyzed and subsequently matched against the present day indications for adjuvant treatment.

Results

During follow-up (median 41 months) only four (6%) patients developed systemic disease. Initially, three of these patients did not receive adjuvant chemotherapy. Two are alive without evidence of disease after treatment of these recurrences. Currently these patients would, initially, all have been eligible for chemotherapy based on tumor characteristics and age according to international guidelines.

Conclusions

For the indication of adjuvant treatment, the status of the internal mammary lymph nodes was not relevant in our patients. Parasternal uptake is not an indication to extend the surgical procedure. J. Surg. Oncol. 2004;87:13–18. © 2004 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.